NHI-2
Product Specifications
CAS Number
1269802-97-2
Target
Apoptosis, Dehydrogenase
Related Pathways
Apoptosis, Metabolism
Purity
0.99981
Bioactivity
NHI-2 is a lactate dehydrogenase A (LDHA) inhibitor with an IC50 value of 14.7 μM, demonstrating high selectivity for LDHA over LDHB, for which the IC50 is 55.8 μM. NHI-2 functions as an efficient anti-glycolytic agent, enhancing apoptosis, inducing cell cycle arrest at the S and G2 phases, and exerting broad-spectrum antiproliferative effects in cancer cells. NHI-2 additionally affects extracellular acidification rates and ATP production and has demonstrated tumor growth suppression in murine B78 melanoma models, highlighting its role in cancer metabolism research.
Smiles
C(F)(F)(F)C1=C2C(N(O)C(C(OC)=O)=C2)=CC(=C1)C3=CC=CC=C3
Molecular Formula
C17H12F3NO3
Molecular Weight
335.28
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1183056 Inquire
Recombinant Clostridium phytofermentans DNA mismatch repair protein MutS (mutS), partial
Sign In for Pricing
View Details